SCHEMBL7845010

SCHEMBL7845010

CCOC(=O)COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OC(CC)N1CCOCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FBP1 P09467 2/20 0.55
▸ EGFR P00533 13/20 0.54
▸ ERBB2 P04626 5/20 0.54
▸ ERBB4 Q15303 2/20 0.54
▸ KDR P35968 5/20 0.51
▸ HDAC3 O15379 4/20 0.51
▸ HDAC4 P56524 4/20 0.51
▸ HDAC1 Q13547 4/20 0.51
▸ HDAC7 Q8WUI4 4/20 0.51
▸ HDAC2 Q92769 4/20 0.51
▸ HDAC10 Q969S8 4/20 0.51
▸ HDAC11 Q96DB2 4/20 0.51
▸ HDAC8 Q9BY41 4/20 0.51
▸ HDAC6 Q9UBN7 4/20 0.51
▸ HDAC9 Q9UKV0 4/20 0.51
▸ HDAC5 Q9UQL6 4/20 0.51
▸ KDM4E B2RXH2 1/20 0.48
▸ GAK O14976 1/20 0.48
▸ MAPK13 O15264 1/20 0.48
▸ ABL1 P00519 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7844855 1.00 FBP1 (0.55) FBP1EGFRERBB2ERBB4KDR
SCHEMBL4230227 0.86 EGFR (0.62) FBP1EGFRERBB2ERBB4KDR
SCHEMBL4222324 0.86 EGFR (0.62) FBP1EGFRERBB2ERBB4KDR
SCHEMBL4231429 0.85 EGFR (0.68) EGFRERBB2KDRHDAC3HDAC1
SCHEMBL4231150 0.85 EGFR (0.68) EGFRERBB2KDRHDAC3HDAC1
SCHEMBL2998293 0.84 EGFR (0.61) FBP1EGFRERBB2ERBB4KDR
SCHEMBL2995000 0.82 FBP1 (0.67) FBP1EGFRERBB2ERBB4KDR
SCHEMBL2996285 0.82 EGFR (0.71) EGFRERBB2ERBB4KDRGAK
SCHEMBL7854521 0.80 EGFR (0.59) FBP1EGFRERBB2ERBB4KDR
SCHEMBL2991327 0.77 EGFR (0.53) EGFRERBB2KDRSRCMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163227-A1 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, AND PROCESSES FOR PREPARING THEM Boehringer Ingelheim Pharma KG (DE) 2001-12-19 — — EP disclosed
WO-2000055141-A1 BICYCLIC HETEROCYCLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, AND PROCESSES FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-21 — — WO disclosed
Send feedback